CUSIP 603170101COMMLYSQ4 2025
22 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Catalys Pacific, LLC | 7.90M | $286.83M |
| 2 | Ra Capital Management, L.P. | 7.32M | $265.78M |
| 3 | Samsara Biocapital, LLC | 5.87M | $213.06M |
| 4 | Fmr LLC | 5.06M | $183.54M |
| 5 | Blackrock, Inc. | 4.33M | $157.05M |
| 6 | Vanguard Group Inc | 3.35M | $121.68M |
| 7 | State Street Corp | 3.18M | $115.58M |
| 8 | Caligan Partners LP | 2.77M | $100.62M |
| 9 | Franklin Resources Inc |
| 4 | Sep 8, 2025 | Samsara Biocapital, L.P. | 13D/A | 8.2% | — | SEC |
| 5 | Sep 8, 2025 | Ra Capital Management, L.P. | 13D/A | 9.9% | — | SEC |
| 6 | Aug 14, 2025 | Andera Partners | 13G/A | 4.2% | 2.77M | SEC |
| 7 | Aug 14, 2025 | Catalys Pacific Fund, LP | 13G/A | 13.5% | 8.98M | SEC |
| 8 | Mar 17, 2025 | Samsara Biocapital, L.P. | 13D/A | 9.1% | — | SEC |
| 9 | Mar 17, 2025 | Ra Capital Management, L.P. | 13D/A | 9.9% | — | SEC |
| 10 | Feb 14, 2025 | Adams Street Partners, LLC | 13G/A | 2.3% | — | SEC |
See the full Schedule 13D/13G history for Mineralys Therapeutics Inc.
Unlock full history| 1.79M |
| $64.91M |
| 10 | Laurion Capital Management LP | 1.71M | $62.18M |